US 7,558,622 B2
`(10) Patent No.:
`a2) United States Patent
`Tran
`(45) Date of Patent:
`Jul. 7, 2009
`
`
`US007558622B2
`
`(54) MESH NETWORK STROKE MONITORING
`APPLIANCE
`
`(76)
`
`:
`(*) Notice:
`
`Inventor: Bao Tran, 6768 Meadow Vista Ct., San
`Jose, CA (US) 95135
`:
`:
`:
`:
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`U.S.C, 154(b) by 440 days.
`
`(21) Appl. No.: 11/439,631
`
`(22)
`
`Filed:
`
`May24, 2006
`
`(65)
`
`Prior Publication Data
`
`US 2007/0276270 Al
`
`Nov. 29, 2007
`
`(51)
`
`Int. Cl.
`(2006.01)
`A6IN 5/04
`(52) U.S. CM ccc ceecneeesreeeeee 600/509; 600/513
`(58) Field of Classification Search ................. 600/528,
`600/509, 513
`See application file for complete search history.
`References Cited
`U.S. PATENT DOCUMENTS
`
`(56)
`
`4,234,926 A
`4,275,742 A
`4,320,767 A
`4,412,545 A
`4,420,000 A
`feetoo ‘
`4595018 A
`46563 19 A
`4679.144 A
`4.778.449 A
`4,807,642 A
`4,819,648 A
`4,862,359 A
`
`11/1980 Wallaceetal.
`6/1981 Faisandier
`3/1982 Villa-Real
`11/1983 Okinoet al.
`12/1983 Bailey
`QSone vancint et al.
`6/1986 Rantala
`4/1987 Bially
`7/1987 Coxetal.
`10/1988 Weberet al.
`2/1989 Brown
`4/1989. Ko
`8/1989 Trivedi etal.
`
`.
`
`4,869,261 A
`9/1989 Penaz
`4,880,013 A
`11/1989 Chio
`4,907,597 A
`3/1990 Chamoun
`pal
`fectatt ‘ 1i000 cuenst
`’
`7
`onnson ¢
`5,090,418 A
`2/1992 Squires et al.
`RE34,015 E
`8/1992 Du
`5,140,990 A
`8/1992 uy al.
`5,161,529 A
`11/1992. Stotts et al.
`5,162,991 A
`11/1992 Chio
`5,271,411 A
`12/1993 Ripley et al.
`5,285,793 A
`2/1994 Slovutetal.
`5,287,859 A
`2/1994 John
`5,309,916 A
`5/1994 Hatschek
`5,331,969 A
`7/1994 Silberstein
`5,361,775 A
`11/1994 Remeset al.
`5,365,426 A
`11/1994 Siegel et al.
`5,368,039 A
`11/1994 Moses
`5,370,126 A
`12/1994 Clifford, Jr.
`5,375,610 A
`12/1994 LaCourseet al.
`5,434,419 A
`7/1995 Decupper
`5,435,316 A
`7/1995 Kruse
`(Continued)
`
`OTHER PUBLICATIONS
`U.S. Appl. No. 10/938,783, filed Sep. 10, 2004, Wen.
`Primary Examiner—Carl H Layno
`Assistant Examiner—Brian T Gedeon
`(74) Attorney, Agent, or Firm—Tran & Associates
`
`(57)
`
`ABSTRACT
`
`A health care monitoring system for a person includes one or
`more wireless nodes forming a wireless mesh network; a
`wearable appliance having a sound transducer coupledto the
`wireless transceiver; and a heart attack or stroke attack sensor
`coupledto the wireless mesh network to communicate patient
`data overthe wireless mesh networkto detect a heart attack or
`a stroke attack,
`
`19 Claims, 18 Drawing Sheets
`
`REMGTE SERVER 200
`
`AUTHORIZED THIRD
`TY (DOCTOR,
`
`FAMILY, EMERGENCY
`SERVICES,
`CAREGIVER, HOSPITAL,
`NURSING HOME, CALL
`GENTER, ETC.) 210
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`50
`52
`[ Ey
`60
`BASE STATION -
`LOCAL SERVER 20
`a
`ry
`Le
`
`a2
`
`
`
`10
`
`=
`
`APPLE 1038
`
`1
`
`APPLE 1038
`
`

`

`US 7,558,622 B2
`
`Page 2
`
`............ 600/526
`
`U.S. PATENT DOCUMENTS
`
`1/2002 Allecksonetal.
`6,336,900 Bl
`4/2002 Reusset al.
`6,364,834 Bl
`4/2002 Amanoetal.
`6,364,842 Bl
`8/1995 Przygoda,Jr. et al.
`5,438,607 A
`4/2002 Xuetal.
`6,368,283 Bl
`8/1995 Davidetal. .....00.. 600/483
`5,441,047 A *
`4/2002 Prueitt
`6,374,614 B2
`10/1995 Adamsetal.
`5,458,620 A
`4/2002 Braunetal.
`6,375,614 Bl
`10/1995 Cusimano
`5,462,065 A
`6/2002 Buietal.
`6,398,727 Bl
`3/1996 Chen etal.
`5,497,781 A
`6/2002 Reusset al.
`6,406,426 Bl
`4/1996 Toomim etal.
`5,505,208 A
`7/2002 Yanget al.
`6,413,223 Bl
`5/1996 Cusimanoet al.
`5,513,651 A
`7/2002. Nenov
`6,416,480 Bl
`8/1996 Davidet al.
`5,544,649 A
`8/2002 Petelenzet al.
`6,433,690 B2
`8/1996 Daviset al.
`5,544,661 A
`8/2002 DeLucaet al.
`6,440,067 BL
`8/1996 Garfield
`5,546,953 A
`9/2002 Ting et al.
`6,443,906 B1
`9/1996 Sramek
`5,551,435 A
`9/2002 Rojas, Jr.
`6,445,299 BL
`9/1996 Moses
`5,551,438 A
`10/2002 Grangeret al.
`6,466,816 B2
`11/1996 Dempsey et al.
`5,579,001 A
`10/2002 Erlebacher
`6,473,640 BL
`12/1996 Dempseyetal.
`5,579,775 A
`11/2002 Frelburgeret al.
`6,475,146 Bl
`12/1996 Kabal
`5,584,298 A
`11/2002 Khairetal.
`6,475,153 Bl
`4/1997 Garfield
`5,623,939 A
`11/2002 Wood
`6,487,442 BL
`5/1997 Cohen
`5,633,910 A
`2/2003 Baura
`6,514,211 BL
`7/1997 Lepkofker
`5,652,570 A
`2/2003 Stark etal.
`6,515,593 BL
`9/1997 Skubick
`5,662,118 A
`3/2003 Khair etal.
`6,533,729 Bl
`9/1997 Langetal.
`5,671,741 A
`4/2003 Westetal.
`6,544,173 B2
`11/1997 Hauptmann
`5,683,425 A
`4/2003 West et al.
`6,544,174 B2
`5,685,316 A * 11/1997 Schookin etal.
`4/2003 Kurnik
`6,546,269 BL
`5,692,215 A
`11/1997 Kutzik et al.
`4/2003 Miele
`6,554,774 Bl
`5,694,940 A
`12/1997 Ungeret al.
`4/2003 Groenewegen
`6,556,860 Bl
`5,708,417 A
`1/1998 Tallman et al.
`7/2003 Cybulski et al.
`6,595,316 B2
`5,709,215 A
`1/1998 Perttu et al.
`
`
`5,710,551 A 7/2003.-Hadas1/1998 Ridgeway 6,597,944 BL
`
`5,720,771 A
`2/1998 Snell
`6,605,038 Bl
`8/2003. Teller et al.
`5,722,420 A
`3/1998 Lee
`6,609,023 Bl
`8/2003 Fischelletal.
`5,733,230 A
`3/1998 Sawchucketal.
`6,612,984 BL
`9/2003 Kerr, II
`5,738,104 A
`4/1998 Lo etal.
`6,615,074 B2
`9/2003 Mickle et al.
`5,738,105 A
`4/1998 Kroll
`6,615,075 B2
`9/2003 _Mlynashetal.
`5,743,268 A
`4/1998 Kabal
`6,616,613 Bl
`9/2003 Goodman
`5,772,603 A
`6/1998 Ohlsson
`6,660,042 BL
`12/2003 Curcie et al.
`5,775,330 A
`7/1998 Kangasetal.
`6,661,161 Bl
`12/2003 Lanzoet al.
`5,776,073 A
`7/1998 Garfield etal.
`6,676,600 BL
`1/2004 Coneroetal.
`5,785,960 A
`7/1998 Rigg etal.
`6,678,549 B2
`1/2004 Cusimano
`5,788,643 A
`8/1998 Feldman
`6,678,551 B2
`1/2004 Maaloufetal.
`5,857,975 A
`1/1999 Golub
`6,687,519 B2
`2/2004 Steueretal.
`5,865,755 A
`2/1999 Golub
`6,705,990 Bl
`3/2004 Gallantet al.
`5,876,350 A
`3/1999 Lo etal.
`6,720,984 Bl
`4/2004 Jorgensenetal.
`5,935,077 A
`8/1999 Ogle
`6,730,038 B2
`5/2004 Gallantetal.
`5,945,112 A
`8/1999 Flynnetal.
`6,740,045 B2
`5/2004 Amano
`5,964,719 A
`10/1999 Costello et al.
`6,747,561 Bl
`6/2004 Reeves
`5,967,975 A
`10/1999 Ridgeway
`6,760,620 B2
`7/2004 Sippens Groenewegen
`5,987,519 A
`11/1999 Peiferet al.
`6,783,492 B2
`8/2004 Domiguez et al.
`5,996,889 A
`12/1999 Fuchset al.
`6,804,656 Bl
`10/2004 Rosenfeldet al.
`6,002,957 A
`12/1999 Finneran
`6,816,266 B2
`11/2004 Varshneyaetal.
`6,004,312 A
`12/1999 Finneran etal.
`6,829,501 B2*
`12/2004 Nielsenetal.
`......0.00... 600/513
`6,010,454 A
`1/2000 Arieffet al.
`6,832,251 BL
`12/2004 Gelvin et al.
`6,014,626 A
`1/2000 Cohen
`6,834,436 B2
`12/2004 Townsendetal.
`6,032,035 A
`2/2000 Websteretal.
`6,843,771 B2
`1/2005 Loetal.
`6,038,469 A
`3/2000 Karlssonetal.
`6,856,291 B2
`2/2005 Mickleet al.
`6,047,202 A
`4/2000 Finneran etal.
`6,865,409 B2
`3/2005 Getsla etal.
`6,050,940 A
`4/2000 Braun et al.
`6,871,211 B2
`3/2005 Labounty et al.
`6,052,619 A
`4/2000 John
`6,882,128 BL
`4/2005 Rahmelet al.
`6,056,671 A
`5/2000 Marmer
`6,887,202 B2
`5/2005 Currie etal.
`6,063,051 A
`5/2000 Stern
`6,898,460 B2
`5/2005 Hoctoretal.
`6,070,140 A
`5/2000 Tran
`6,907,288 B2
`6/2005 Daum
`6,076,011 A
`6/2000 Hoover
`6,912,420 B2
`6/2005 Scheineretal.
`6,108,685 A
`8/2000 Kutzik etal.
`6,944,496 B2
`9/2005 Jeong et al.
`6,171,237 Bl
`1/2001 Avital
`6,961,285 B2
`11/2005 Niemiecet al.
`6,175,308 Bl
`1/2001 Tallman etal.
`6,965,794 B2
`11/2005 Brody
`6,176,831 Bl
`1/2001 Vossetal.
`6,973,344 B2
`12/2005 Finneran etal.
`6,184,797 BL
`2/2001 Stark etal.
`6,974,419 BL
`12/2005 Vossetal.
`6,228,034 Bl
`5/2001 Vosset al.
`6,975,206 B2
`12/2005 Reining
`
`6,230,056 Bl=5/2001 Kroll 6,980,852 B2 12/2005 Jersey-Willuhnet al.
`
`6,246,894 BL
`6/2001 Steueretal.
`6,989,751 B2
`1/2006 Richards
`6,280,393 Bl
`8/2001 Grangeret al.
`7,004,907 B2
`2/2006 Banetet al.
`6,287,252 Bl
`9/2001 Lugo
`7,011,629 B2
`3/2006 Bulat
`6,299,583 Bl
`10/2001 Eggerset al.
`7,035,679 B2
`4/2006 Addisonet al.
`
`2
`
`

`

`US 7,558,622 B2
`
`Page 3
`
`5/2006 Baura
`7,043,293 Bl
`7,285,090 B2* 10/2007 Stivoric et al. 00.0.0... 600/300
`2002/0120184 Al
`8/2002 Beck etal.
`2003/0004421 Al
`1/2003 Ting et al.
`2003/0125635 Al
`7/2003 Maaloufetal.
`2003/0135127 Al
`7/2003 Sackneret al.
`2003/0216630 Al
`11/2003 Jersey-Willuhnetal.
`2003/0216662 Al
`11/2003 Jersey-Willuhnetal.
`2003/0216663 Al
`11/2003 Jersey-Willuhnetal.
`2003/0231115 Al
`12/2003 Stannersetal.
`2004/0044273 Al
`3/2004 Kieth etal.
`2004/0102683 Al
`5/2004 Khanuja etal.
`2004/0122487 Al
`6/2004 Hatlestadetal.
`2004/0138568 Al
`7/2004 Loet al.
`2004/0167409 Al
`8/2004 Loet al.
`2004/0167417 Al
`8/2004 Schulhauseretal.
`2004/0220490 Al
`11/2004 Appelet al.
`2004/0254493 Al
`12/2004 Chervinet al.
`2004/0260188 Al
`12/2004 Syedetal.
`2004/0267148 Al
`12/2004 Arandetal.
`2005/0038345 Al
`2/2005 Gorgenburget al.
`2005/0061568 Al
`3/2005 Schondorfetal.
`2005/0079871 Al
`4/2005 Kirket al. ow. 455/446
`2005/0099387 Al
`5/2005 Matsumoto
`2005/0113630 Al
`5/2005 Fox etal.
`2005/0113710 Al
`5/2005 Stahmannetal.
`
`2005/0115561 Al
`2005/0143667 Al
`2005/0148882 Al*
`2005/0194926 Al
`2005/0201585 Al
`2005/0209521 Al
`2005/0222515 Al
`2005/0228244 Al
`2005/0228299 Al
`2005/0228316 Al
`2005/0240086 Al
`2005/0240523 Al
`2005/0245831 Al
`2005/0261594 Al
`2005/0261598 Al
`2005/0278409 Al
`2006/0009697 Al
`2006/0009698 Al
`2006/0047215 Al
`2006/0079801 Al
`2006/0082727 Al
`2006/0084878 Al
`2006/0094975 Al
`2006/0105357 Al
`
`6/2005 Stahmann etal.
`6/2005 Parketal.
`7/2005 Banet etal... 600/485
`9/2005 Di Stefano etal.
`9/2005 Jannardetal.
`9/2005 Kettunenet al.
`10/2005 Polyshchuketal.
`10/2005 Banetetal.
`10/2005 Banetetal.
`10/2005 Morgensternetal.
`10/2005 Akayetal.
`10/2005 Richardsonetal.
`11/2005 Banetetal.
`11/2005 Banetetal.
`11/2005 Banetetal.
`12/2005 Kutzik etal.
`1/2006 Banetetal.
`1/2006 Banetetal.
`3/2006 Newman etal.
`4/2006 DeLucaetal.
`4/2006 Bolger etal.
`4/2006 Banetetal.
`5/2006 Manto
`5/2006 Beneschetal.
`
`* cited by examiner
`
`3
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 1 of 18
`
`US 7,558,622 B2
`
`REMOTE SERVER 200
`
`
`AUTHORIZED THIRD
`
`PARTY (DOCTOR,
`FAMILY, EMERGENCY
`
`SERVICES,
`CAREGIVER, HOSPITAL,
`NURSING HOME,CALL
`CENTER, ETC.) 210
`
`
`Internet
`100
`
`
`
`
`
`LOCAL SERVER 20
`
`Le] Le] Lx} LJ
`
`BASE STATION-
`
`Mesh Network
`
`Appliances 8
`
`Cc)
`
`40
`
`30
`
`FIG. 1
`
`4
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 2 of 18
`
`US 7,558,622 B2
`
`Place a calibration sheet with known dots at a known distance
`and perpendicular to a camera view
`
`Take snap shot of the sheet, and correlate the position of the
`dots to the camera image
`
`Place a different calibration sheet that contains known dotsat
`another different known distance and perpendicular to camera
`view.
`
`defining a cone center where the camera can view
`
`Take snap shot of the sheet and correlate the position of the
`dots to the camera image
`
`Smooth the dots to the pixels to minimize digitization errors
`
`For each pixel, draw a line from Dotl(x,y,z) to Dot2 (x, y, z)
`
`FIG, 2A
`
`enoececedc
`
`om cocmomnods
`
`eocececed
`
`omomogsos
`
`ecec ec edn
`
`omomogos
`
`eoeoce@enoneda
`
`omOHOROE
`
`7Q) NWw
`
`on
`
`5
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 3 of 18
`
`US 7,558,622 B2
`
`Find floor space area
`
`Calculate patient’s key features
`
`FIG. 3
`
`Define camera view
`background 3D scene
`
`Detectfall
`Detect facial expression
`
`Find floor space area
`
`Define camera view background 3D scene
`
`Calculate patient’s key features
`
`Extract facial objects
`
`Detect facial orientation
`
`FIG. 4
`
`6
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 4 of 18
`
`US 7,558,622 B2
`
`
`
`Set up mesh network appliances (1000)
`Determine patient position using in-door positioning system (1002)
`
`Determine patient movementusing accelerometer output (1004)
`
`
`
`
`
`
`
`
`
`
`
`Determine vital parameter including patient heart rate (1006)
`
` Determine if patient needs assistance based on in-doorposition,fall
`
`detection and vital parameter (1008)
`
`
`If confirmed or non-responsive, make connection with third party and
` send voice over mesh network to appliance worn by the patient (1012)
`
`
`If needed, call emergency personnel to get medical care (1014)
`FIG. 5
`
`Confirm prior to calling third party (1010)
`
`1382
`
`1388
`
`FIG. 6A
`
`7
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 5 of 18
`
`US 7,558,622 B2
`
`HDTV REMOTE
`CONTROL1399
`
`LIGHTING
`CONTROL1398
`
`ROOM
`THERMOSTAT
`CONTROL 1396
`
`HEAD BAND OR HEAD CAP
`1402
`
`PATCH
`1400
`
`MEDICINE
`CONTAINER(S)
`
`
`
`1182
`1391 HOME
`
`HOME SECURITY
`MONITOR 1394
`
`FIRE ALARMS
`1393
`
`1392
`
`
`BASE STATION
`
`POTS/PSTN OR THE
`OR PERSONAL
`INTERNET
`
`
`SERVER 1390
`
`APPLIANCE(S)
`
`AUTHORIZED THIRD PARTY (FRIEND, FAMILY, COMMUNITY, EMERGENCY SERVICES,
`HOSPITAL, CAREGIVER, OR MONITORING CALL CENTER, AMONG OTHERS) 1194
`
`
`
`FIG. 6B
`
`8
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet6 of 18
`
`US 7,558,622 B2
`
`Star @ PAN Coordinator (FFD)
`
`©) Router Node (FFD)
`@ End Device (RFD or FFD)
`
`FIG. 7
`
`130
`
`132
`
`FIG. 8
`
`9
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 7 of 18
`
`US 7,558,622 B2
`
`4
`27s }
`ene
`
`\
`
`)
`
`“Tey
`_
`
`L
`4
`j
`’
`(
`‘A ‘
`\
`
`149
`
`10
`
`

`

`US 7,558,622 B2
`
`U.S. Patent
`
`162
`
`Jul. 7, 2009
`
`Sheet 8 of 18
`
`172
`
`FIG. 11
`
`
`
`11
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 9 of 18
`
`US 7,558,622 B2
`
`FIG. 13
`
`FIG. 14B
`
`
`ry
`
`190
`
`192
`
`196
`
`‘‘
`
`}An
`
`?satrnselenho
`Nyapti!
`ihyMi:
`3h
`
`FIG. 14A
`
`12
`
`12
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 10 of 18
`
`US 7,558,622 B2
`
`
`
`
`
`(NOLWISS.3SYNN‘be)
`
`
`
`IN3NOYYOMLINw
`
`LLE
`
`S3SYNN
`
`YILAdWOD
`
`S3SYNN
`
`YALNdNOD
`
`YaAN3S
`
`LN3UVd
`
`ISVEVLVG
`
`
`
`WALISSOH|\ge7
`
`WaOs3AVM
`
`Y3AN3S
`
`at#iNav
`YALLIWSNVaL
`
`me,et eeee eeee
`eeen
`‘ovis nbn aman, SNUG rere een? ee
`
`LNIULY
`‘Nae
`
`ifANBILWd
`
`
`
`WalLINSNYSL
`
`FIG. 15A
`
`13
`
`13
`
`
`
`
`
`
`
`
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 11 of 18
`
`US 7,558,622 B2
`
`
`
`IN3TDHOMLIN
`
`LLE
`
`
`
`LY39V¢SN3O7]vO
`
`S3SYNN
`
`YALNGNOD
`
`— ee
`
`cannedoReeteeeooee oy
`Y3ANIS
`
`”Oe
`
`
`
` LNIUVd:WLIdSOH|Noer|4hinhsseatstdNieikokalkaeeea
`
`asvavivo
`
`:SOF
`
`Q3iA'
`
`NGAM3S
`
`WHOABAVM
`
`£0f~|087
`
`}
`
`werwmenKgfeeen===wwee
`
`
`
`‘came mnenes Mam ervO=SEMAINE!0TE rere, ee eee
`
`ANSIVd
`Nee
`
`t#ANBILWd
`
`ALLINSNYAL
`
`UaLLINSNYELZ#LNGLYd
`
`FIG. 15B
`
`14
`
`14
`
`
`
`
`
`
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 12 of 18
`
`US 7,558,622 B2
`
`Patient A
`
`Patient B
`
`Patient C
`
`bees
`
`Patient N
`
`A,
`1 re oc ore S
`
`
`
`BPAAAY
`~
`LyeOR ReON
`
`
`
`
`
`deg
`i ae re os
`
`aaaaaes
`
`SOORGTEa it 7
`
`we DL oh a
`
`ALERT
`
`i ee
`aMVAVACACAU)
`be ry
`LheOneELOY
`
`BLE RRL A
`
`BARRA La
`
`‘
`
`Soe SL eee
`
`reg Behe vead
`aMV AUAVATAC
`EEROTOLLT
`aedlee:
`
`“a roa area were
`
`a; wywae
`
`nya
`Aver
`Oean
`Saapoet mF
`
`ALRR Ad
`
`VACACkCae,Pa
`AeA CLONING
`
`TaPs
`
`aetene
`jis
`{s ee Oe eee
`
` = ay 7 PsSete
`
`
`peebeuhadK:WO) ML Sakased
`
`Srna
`
`ane
`
`ia
`
`
`ie (Ean
`
`FIG. 15C
`
`FIG. 15D
`
`15
`
`15
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 13 of 18
`
`US 7,558,622 B2
`
`-
`
`. a ohba .
`
`}
`
`we. “ee Ta} ettai .
`
`a
`
`ite Be oe
`
`™
`aeMem,PeMthfeetRMSNM Ta
`
`Mt
`
`mS
`
`tStewaies—
`Weiert
`Sada:
`oea. + ac.
`M a
`oop eoseee aegeneLemecore ”See SERIE Oreo or eee cereee ee
`FIG. 15F
`
`f
`
`16
`
`16
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 14 of 18
`
`US 7,558,622 B2
`
`Generate a blood pressure modelof a patient (2002)
`
`continuously estimate blood pressure (2006)
`
`Determinea blood flow velocity using a piezoelectric transducer (2004)
`
`Provide.the blood flow velocity to the blood pressure modelto
`
`FIG. 16A
`
`Attach monitoring device and calibration device to patient (2010)
`
`Determine blood flow velocity from the monitoring device and actual
`blood pressure from the calibration device (2012)
`
`Generate a blood pressure model based onthe blood flow velocity and the
`actual blood pressure (2014)
`
`pressure (2020)
`
`Removecalibration device (2016)
`
`Determine blood flow velocity (2018)
`
`Provide blood flow velocity to the blood pressure modelto estimate blood
`
`FIG. 16B
`17
`
`17
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 15 of 18
`
`US 7,558,622 B2
`
`Detect weaknessin left half and right half of patient body - arms, legs,
`face (3000)
`
`Detect walking pattern for loss of balance or coordination (3002)
`
`Askuser to move hands/feet in a predetermined pattern (3004)
`
`during squeeze (3018)
`
`Read accelerometer output in accordance with predetermined pattern
`movement(3006)
`
`Provide accelerometer output to a pattern classifier (3008)
`
`Check whether patient is experiencing dizziness or sudden, severe
`headache with no known cause (3010)
`
`Display a text image andask the patient to read back the text image,
`one eye at a time (3012)
`
`Use speech recognizer to detect confusion, trouble speaking or
`understanding (3014)
`
`Askpatient if they feel numbnessin the body- arms,legs, face (3016)
`
`Askpatient to squeeze gauge/force sensor to determine force applied
`
`FIG. 16C
`
`18
`
`18
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 16 of 18
`
`US 7,558,622 B2
`
`Torso
`
`Right
`upper
`arm
`
`
`
`Left
`thigh
`
`Right
`thigh
`
`
`
`
`
`
`Left
`lower
`arm
`
`
`Right
`lower
`
`arm
`
`
`Right
`calf
`
`FIG. 16D
`
`19
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 17 of 18
`
`US 7,558,622 B2
`
`Comparehistorical right shoulder (RS) strength against current
`RS strength (3202)
`
`Comparehistorical left hip (LH) strength against current LH
`strength (3204)
`
`Comparehistorical left shoulder (LS) strength against current LS
`strength (3200)
`
`threshold, generate warning (3208)
`
`Comparehistorical right hip (RH) strength against current RH
`strength (3206)
`
`If variance betweenhistorical and current strength exceeds
`
`FIG. 16E
`
`20
`
`20
`
`

`

`U.S. Patent
`
`Jul. 7, 2009
`
`Sheet 18 of 18
`
`US 7,558,622 B2
`
`Muscle site
`
` 16mm
`
`Vour = Vi-V2
`
`+mm
`
`f
`
`Reference
`
`FIG. 17A
`
`HISTORICAL MEASUREMENT
`
`RECENT MEASUREMENT
`
`
`
`FIG. 17B
`
`FIG. 17C
`
`21
`
`21
`
`

`

`US 7,558,622 B2
`
`1
`MESH NETWORK STROKE MONITORING
`APPLIANCE
`
`BACKGROUND
`
`This invention relates generally to methods and systemsfor
`monitoring a person.
`Stroke is the third-leading cause of death in the United
`States. A stroke is defined as a suddenloss of brain function
`
`caused by a blockageor rupture of a blood vessel to the brain.
`Approximately 150,000 deaths per year are attributed to
`stroke. It is also the most common neurologic reason for
`hospitalization. A stroke occurs when a blood vessel (artery)
`that supplies bloodto the brain bursts or is blocked by a blood
`clot. Within minutes, the nerve cells in that area of the brain
`are damaged, and they may die within a few hours. Asa result,
`the part of the body controlled by the damaged section of the
`brain cannot function properly.Prior to a stroke, a person may
`have one or moretransient ischemic attacks (TIAs), which are
`a warning signalthat a stroke may soon occur. TIAsare often
`called mini strokes because their symptomsare similar to
`those of a stroke. However, unlike stroke symptoms, TIA
`symptoms usually disappear within 10 to 20 minutes,
`although they maylast up to 24 hours.
`Althoughgreat strides have been madein the treatment of
`stroke, the overall incidence will continueto rise as our popu-
`lation ages. Primary and secondary prevention of stroke is
`importantto decreaseits incidence andits associated morbid-
`ity. The 30-day mortality rate is 7.6% for patients with
`ischemic stroke and 37.5% for those with hemorrhagic
`stroke.17 Most deaths within the first week are attributable to
`the severe nature of a stroke, while deaths that occurlater are
`usually the result of complications of the stroke itself or of
`other comorbid conditions. Patients with stroke often have
`systemic vascular disease; the annualrisk ofvascular death in
`stroke patients is greater than 3%. Most stroke survivors are
`left with somedisability. For example, 48% are hemipareticat
`6 months and 22% cannot walk. As many as one-half ofall
`stroke survivors are partially dependent on others to perform
`activities of daily living.18 The rate of recurrent noncardi-
`oembolic stroke is 3% to 7% per year.
`Stroke can be subdivided into two types: ischemic and
`hemorrhagic. Ischemic stroke accounts for 85% ofall cas-
`es.In ischemic stroke, interruption of the blood supply to the
`brain results in tissue hypoperfusion, hypoxia, and eventual
`cell death secondary to a failure of energy production. Three
`main mechanisms are involved in the development of
`ischemic stroke, and they are associated with atherothrom-
`botic, embolic, and small-vessel diseases. Less common
`causes include coagulopathies, vasculitis, dissection, and
`venous thrombosis.
`In atherothrombotic disease, lipid deposition leads to the
`formation of plaque, which narrows the vessel lumen and
`results in turbulent blood flow through the area of stenosis.
`The turbulenceofthe flow and the resultantalterationsin flow
`velocities lead to intimal disruption or plaque rupture, both of
`which activate the clotting cascade. This causesplatelets to
`becomeactivated and adhere to the plaque surface, where
`they eventually form a fibrin clot. As the lumenofthe vessel
`becomes more occluded,
`ischemia develops distal to the
`obstruction and can eventually lead to an infarction of the
`tissue that is dependenton the parent vessel for oxygen deliv-
`ery. Embolic stroke occurs when dislodged thrombitravel
`distally and occlude vessels downstream. One-half of all
`embolic strokes are caused by atrial fibrillation; the rest are
`attributable to a variety of causes, including (1) left ventricu-
`lar dysfunction secondary to acute myocardial infarction or
`
`2
`severe congestive heart failure, (2) paradoxical emboli sec-
`ondary to a patent foramen ovale, and (3) atheroemboli.
`Theselatter vessel-to-vessel emboli often arise from athero-
`
`sclerotic lesions in the aortic arch, carotid arteries, and ver-
`tebral arteries.
`Small-vessel ischemia can occur when microatheromata
`
`occlude the orifice of penetrating arteries. Another mecha-
`nism is associated with lipohyalinosis, in which pathologic
`changes in the tunica media and the adventitia of penetrating
`arteries occur in the presence of chronic hypertension.
`Elevated blood pressure causes endothelial injury that dis-
`rupts the blood-brain barrier. This in turn leads to a deposition
`of plasma proteins and eventually degeneration of the tunica
`media smooth muscle. The smooth muscle is replaced with
`collagenous fibers, which inhibit the elasticity of the blood
`vessel. This causes the vessel lumen to narrow and eventually
`activates the clotting cascade, leading to thrombosis. Small-
`vessel ischemic disease typically results in lacunar infarcts,
`which were named for the small “lakes” (lacunae) that are
`foundat autopsy in affected patients.
`Hypoperfusion can occur as a result of (1) atherosclerotic
`disease that limits distal flow or (2) systemic hypotension,
`such as seen in patients who experience acute cardiacarrhyth-
`mia or cardiac arrest. A reduction in cerebral perfusion pres-
`sure activates the autoregulatory system. As the smallarteri-
`oles constrict in an attempt to maintain pressure, ischemia can
`develop in the distal branchesofthe vasculartree. Areas ofthe
`brain that lies between two major vascular supplies (eg, the
`middle and anterior cerebral arteries) is known as a watershed
`area. These areas are especially prone to ischemia during
`episodes of systemic hypotension.
`Hemorrhagic stroke can be further subclassified as intrac-
`erebral and subarachnoid. Intracerebral hemorrhage is the
`result of the rupture of a vessel within the brain parenchyma.
`The primary causes of these ruptures are hypertension and
`amyloid angiopathy; secondary precipitating factors are
`listed in Table 1. As with ischemic stroke, the location of an
`intracerebral hemorrhage determines the type of symptoms
`and the patient’s overall outcome. For example, a small lobar
`hemorrhage might cause only a mild headache and subtle
`motor deficits, while a hemorrhage of the same size in the
`pons might result in a coma. Outcomesare also correlated
`with the volumeofblood; hemorrhagesgreater than 60 ml are
`almost alwaysfatal, regardless of their location.
`Hypertension is a major cause of hemorrhagesofthe basal
`ganglia and brainstem. Chronic hypertension can lead to the
`formation of Charcot-Bouchard aneurysmsin lipohyalinotic
`vessels, which can rupture. Commonlocations of hyperten-
`sive hemorrhages include the putamen, caudate, thalamus,
`pons, and cerebellum. Amyloid angiopathy is a common
`cause of lobar hemorrhage (FIG. 5). This disease process
`occurs in the elderly and is caused by a deposition of beta
`amyloid sheets in the tunica media of the vessel wall. The
`deposition of amyloid protein causes the vessels to become
`morerigid, fragile, and prone to rupture. Evidence of hemo-
`siderin deposition in other areas of the brain on magnetic
`resonance imaging (MRI) might also be seen. This deposition
`indicates that the patient has experienced previous hemor-
`rhage andprovides indirect support for the presence of amy-
`loid angiopathy; however, pathologic examination can make
`a definitive diagnosis.
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`22
`
`22
`
`

`

`US 7,558,622 B2
`
`3
`Early detection and treatment of stroke is essential to
`recovery from a stroke.
`
`SUMMARY
`
`In one aspect, a monitoring system for a person includes
`one or more wireless nodes and a stroke sensor coupled to the
`person andthe wireless nodes to determinea stroke attack.
`In one aspect, a monitoring system for a person includes
`one or more wireless nodes and an electromyography (EMG)
`sensor coupled to the person and the wireless nodes to deter-
`mine a stroke attack.
`
`In another aspect, a health care monitoring system for a
`person includes one or more wireless nodes forming a wire-
`less mesh network; a wearable appliance having a sound
`transducer coupled to the wireless transceiver; and a bioelec-
`tric impedance (BJ) sensor coupled to the wireless mesh
`network to communicate BI data over the wireless mesh
`network.
`
`In a further aspect, a heart monitoring system for a person
`includes one or more wireless nodes forming a wireless mesh
`network and a wearable appliance having a sound transducer
`coupled to the wireless transceiver; and a heart disease rec-
`ognizer coupled to the soundtransducer to determine cardio-
`vascular health and to transmit heart sound over the wireless
`
`mesh networkto a remotelistenerif the recognizer identifies
`a cardiovascular problem. The heart sound being transmitted
`may be compressed to save transmission bandwidth.
`In yet another aspect, a monitoring system for a person
`includes one or more wireless nodes; anda wristwatch having
`awireless transceiver adapted to communicate with the one or
`more wireless nodes; and an accelerometer to detect a dan-
`gerous condition and to generate a warning whenthe danger-
`ous condition is detected.
`
`In yet another aspect, a monitoring system for a person
`includes one or more wireless nodes forming a wireless mesh
`network; and a wearable appliance having a wireless trans-
`ceiver adapted to communicate with the one or more wireless
`nodes; and a heartbeat detector coupled to the wireless trans-
`ceiver. The system may also include an accelerometer to
`detect a dangerous condition suchasa falling condition andto
`generate a warning whenthe dangerous condition is detected.
`Implementations of the above aspect may include one or
`more of the following. The wristwatch determines position
`based on triangulation. The wristwatch determines position
`based on RF signal strength and RF signal angle. A switch
`detects a confirmatory signal from the person. The confirma-
`tory signal includes a head movement, a hand movement, or
`a mouth movement. The confirmatory signal includes the
`person’s voice. A processorin the system executes computer
`readable codeto transmit a help request to a remote computer.
`The code can encrypt or scramble data for privacy. The pro-
`cessor can execute voice over IP (VOIP) code to allow a user
`and a remote person to audibly communicate with each other.
`The voice communication system can include Zigbee VOIP
`or Bluetooth VOIP or 802.XX VOIP. The remote person can
`be a doctor, a nurse, a medical assistant, or a caregiver. The
`system includes code to store and analyze patient informa-
`tion. The patient information includes medicine taking habits,
`eating and drinking habits, sleeping habits, or excise habits. A
`patient interface is provided on a user computerfor accessing
`information andthe patient interface includes in one imple-
`mentation a touch screen; voice-activated text reading; and
`one touch telephonedialing. The processor can execute code
`to store and analyze information relating to the person’s
`ambulation. A global positioning system (GPS)receiver can
`be used to detect movement and where the person falls. The
`
`4
`system can include code to mapthe person’s location onto an
`area for viewing. The system can include one or more cam-
`eras positioned to capture three dimensional (3D)video ofthe
`patient; and a server coupledto the one or more cameras, the
`server executing code to detect a dangerous condition for the
`patient based on the 3D video and allow a remote third party
`to view images ofthe patient when the dangerous conditionis
`detected.
`
`In another aspect, a monitoring system for a person
`includes one or more wireless bases; and a cellular telephone
`having a wireless transceiver adapted to communicate with
`the one or more wireless bases; and an accelerometerto detect
`a dangerous condition and to generate a warning when the
`dangerous condition is detected.
`In yet another aspect, a monitoring system includes one or
`more cameras to determine a three dimensional (3D) model
`of a person; meansto detect a dangerous condition based on
`the 3D model; and means to generate a warning when the
`dangerous condition is detected.
`In another aspect, a methodto detect a dangerous condition
`for an infant includes placing a pad with one or more sensors
`in the infant’s diaper; collecting infant vital parameters; pro-
`cessing the vital parameter to detect SIDS onset; and gener-
`ating a warning.
`Advantages of the system may include one or more of the
`following. The system detects the warning signs of stroke and
`promptstheuserto reach a health care provider within 2 hours
`of symptom onset. The system enables patent to properly
`manageacute stroke, andthe resulting early treatment might
`reduce the degree of morbidity that is associated withfirst-
`ever strokes.
`
`Other advantagesofthe invention may include one or more
`ofthe following. The system for non-invasively and continu-
`ally monitors a subject’s arterial blood pressure, with reduced
`susceptibility to noise and subject movement, and relative
`insensitivity to placement ofthe apparatus on the subject. The
`system does not need frequent recalibration of the system
`while in use on the subject.
`In particular, it allows patients to conduct a low-cost, com-
`prehensive, real-time monitoring of their blood pressure.
`Using the web services software interface, the invention then
`avails this information to hospitals, home-health care organi-
`zations, insurance companies, pharmaceutical agencies con-
`ducting clinical trials and other organizations. Information
`can be viewed using an Internet-based website, a personal
`computer, or simply by viewing a display on the monitor.
`Data measured several times each day provide a relatively
`comprehensive data set compared to that measured during
`medical appointments separated by several weeks or even
`months. This allows boththe patient and medical professional
`to observe trends in the data, such as a gradual increase or
`decrease in blood pressure, which may indicate a medical
`condition. The invention also minimizeseffects ofwhite coat
`
`syndrome since the monitor automatically makes measure-
`ments with basically no discomfort; measurements are made
`at the patient’s homeor work,rather than in a medicaloffice.
`The wearable appliance is small, easily worn by the patient
`during periods of exercise or day-to-day activities, and non-
`invasively measures blood pressure can be done in a matter of
`seconds without affecting the patient. An on-board or remote
`processor can analyze the time-dependent measurements to
`generate statistics on a patient’s blood pressure (e.g., average
`pressures, standard deviation, beat-to-beat pressure varia-
`tions) that are not available with conventional devices that
`only measure systolic and diastolic blood pressure atisolated
`times.
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`23
`
`23
`
`

`

`US 7,558,622 B2
`
`5
`The wearable appliance provides an in-depth, cost-effec-
`tive mechanism to evaluate a patient’s cardiac condition.
`Certain cardiac conditions can be controlled, and in some
`cases predicted, before they actually occur. Moreover, data
`from the patient can be collected and analyzed while the
`patient participates in their normal, day-to-day activities.
`In cases where the device has fall detection in addition to
`
`blood pressure measurement, other advantages of the inven-
`tion may include one or more of the following. The system
`provides timely assistance and enables elderly and disabled
`individuals to live relatively independent lives. The system
`monitors physical activity patterns, detects the occurrence of
`falls, and recognizes body motion patterns leading to falls.
`Continuous monitoring of patients is done in an accurate,
`convenient, unobtrusive, private and socially acceptable man-
`ner since a computer monitors the images and humaninvolve-
`ment
`is allowed only under pre-designated events. The
`patient’s privacy is preserved since humanaccess to videos of
`the patientis restricted: the system only allows humanview-
`ing under emergency or other highly controlled conditions
`designated in advanceby the user. Whenthe patientis healthy,
`people cannot view the patient’s video without the patient’s
`consent. Only when the patient’s safety is threatened would
`the system provide patient information to authorized medical
`providers to assist the patient. When an emergency occurs,
`images of the patient and related medical data can be com-
`piled a